메뉴 건너뛰기




Volumn 22, Issue 5, 2009, Pages 495-502

The normal hematocrit cardiac trial revisited

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BLOOD; HEART INFARCTION; HEMATOCRIT; HUMAN; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

EID: 70350025093     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00620.x     Document Type: Article
Times cited : (13)

References (35)
  • 1
    • 0032572913 scopus 로고    scopus 로고
    • The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA : The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 : 584 590, 1998
    • (1998) N Engl J Med , vol.339 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3    Egrie, J.C.4    Nissenson, A.R.5    Okamoto, D.M.6    Schwab, S.J.7    Goodkin, D.A.8
  • 2
    • 0037317068 scopus 로고    scopus 로고
    • A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients
    • Furuland H, Linde T, Ahlmén J, Christensson A, Strömbom U, Danielson BG : A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplan 18 : 353 361, 2003
    • (2003) Nephrol Dial Transplan , vol.18 , pp. 353-361
    • Furuland, H.1    Linde, T.2    Ahlmén, J.3    Christensson, A.4    Strömbom, U.5    Danielson, B.G.6
  • 3
    • 27144498003 scopus 로고    scopus 로고
    • Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
    • for the Canadian European Study Group:
    • Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D, for the Canadian European Study Group : Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16 : 2180 2189, 2005
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2180-2189
    • Parfrey, P.S.1    Foley, R.N.2    Wittreich, B.H.3    Sullivan, D.J.4    Zagari, M.J.5    Frei, D.6
  • 4
    • 66449096808 scopus 로고    scopus 로고
    • Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial
    • Foley RN, Curtis BM, Parfrey PS : Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 4 : 726 733, 2009
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 726-733
    • Foley, R.N.1    Curtis, B.M.2    Parfrey, P.S.3
  • 6
    • 33750983605 scopus 로고    scopus 로고
    • Correction of anemia with epoetin alfa in chronic kidney disease
    • for the CHOIR Investigators:
    • Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, for the CHOIR Investigators : Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 : 2085 2098, 2006
    • (2006) N Engl J Med , vol.355 , pp. 2085-2098
    • Singh, A.K.1    Szczech, L.2    Tang, K.L.3    Barnhart, H.4    Sapp, S.5    Wolfson, M.6    Reddan, D.7
  • 7
    • 33846669860 scopus 로고    scopus 로고
    • Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis
    • Phrommintikul A, Haas SJ, Elsik M, Krum H : Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 : 381 388, 2007
    • (2007) Lancet , vol.369 , pp. 381-388
    • Phrommintikul, A.1    Haas, S.J.2    Elsik, M.3    Krum, H.4
  • 8
    • 38549092225 scopus 로고    scopus 로고
    • The normal hematocrit study - Follow-up
    • for the Normal Hematocrit Cardiac Trial Authors
    • Besarab A, Goodkin DA, Nissenson AR, for the Normal Hematocrit Cardiac Trial Authors : The normal hematocrit study - follow-up. N Engl J Med 358 : 433 434, 2008
    • (2008) N Engl J Med , vol.358 , pp. 433-434
    • Besarab, A.1    Goodkin, D.A.2    Nissenson, A.R.3
  • 14
    • 66149151415 scopus 로고    scopus 로고
    • Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States
    • Zhang Y, Thamer M, Cotter D, Kaufman J, Hernán MA : Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol 4 : 638 644, 2009
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 638-644
    • Zhang, Y.1    Thamer, M.2    Cotter, D.3    Kaufman, J.4    Hernán, M.A.5
  • 16
    • 0034865076 scopus 로고    scopus 로고
    • Cardiovascular effects of erythropoietin and anemia correction
    • Vaziri ND : Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens 10 : 633 637, 2001
    • (2001) Curr Opin Nephrol Hypertens , vol.10 , pp. 633-637
    • Vaziri, N.D.1
  • 17
    • 44649121569 scopus 로고    scopus 로고
    • Thrombosis with erythropoietic stimulating agents - Does iron-deficient erythropoiesis play a role?
    • Dahl NV, Henry DH, Coyne DW : Thrombosis with erythropoietic stimulating agents - does iron-deficient erythropoiesis play a role? Semin Dial 21 : 210 211, 2008
    • (2008) Semin Dial , vol.21 , pp. 210-211
    • Dahl, N.V.1    Henry, D.H.2    Coyne, D.W.3
  • 19
    • 60349120822 scopus 로고    scopus 로고
    • Intravenous iron versus erythropoiesis-stimulating agents: Friends or foes in treating chronic kidney disease anemia?
    • Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR : Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 16 : 143 151, 2009
    • (2009) Adv Chronic Kidney Dis , vol.16 , pp. 143-151
    • Kalantar-Zadeh, K.1    Streja, E.2    Miller, J.E.3    Nissenson, A.R.4
  • 21
    • 0031776172 scopus 로고    scopus 로고
    • Effects of epoetin alfa on hemostasis in chronic renal failure
    • Tang WW, Stead RA, Goodkin DA : Effects of epoetin alfa on hemostasis in chronic renal failure. Am J Nephrol 18 : 263 273, 1998
    • (1998) Am J Nephrol , vol.18 , pp. 263-273
    • Tang, W.W.1    Stead, R.A.2    Goodkin, D.A.3
  • 22
    • 1942506496 scopus 로고    scopus 로고
    • Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin
    • Roman RMB, Lobo PI, Taylor RP, Goodkin DA, LaBrecque J, Powers KL, Bolton WK : Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin. J Am Soc Nephrol 15 : 1339 1346, 2004
    • (2004) J Am Soc Nephrol , vol.15 , pp. 1339-1346
    • Roman, R.M.B.1    Lobo, P.I.2    Taylor, R.P.3    Goodkin, D.A.4    Labrecque, J.5    Powers, K.L.6    Bolton, W.K.7
  • 23
    • 44649160130 scopus 로고    scopus 로고
    • From anemia trials to clinical practice: Understanding the risks and benefits when setting goals for therapy
    • Coyne DW : From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy. Semin Dial 21 : 212 216, 2008
    • (2008) Semin Dial , vol.21 , pp. 212-216
    • Coyne, D.W.1
  • 24
    • 0036690660 scopus 로고    scopus 로고
    • Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
    • Dodd RY, Notari EP, Stramer SL : Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 : 975 979, 2002
    • (2002) Transfusion , vol.42 , pp. 975-979
    • Dodd, R.Y.1    Notari, E.P.2    Stramer, S.L.3
  • 25
    • 15244343326 scopus 로고    scopus 로고
    • Transfusion-related acute lung injury
    • Silliman CC, Ambruso DR, Boshkov LK : Transfusion-related acute lung injury. Blood 105 : 2266 2273, 2005
    • (2005) Blood , vol.105 , pp. 2266-2273
    • Silliman, C.C.1    Ambruso, D.R.2    Boshkov, L.K.3
  • 26
    • 29744451951 scopus 로고    scopus 로고
    • Transfusion safety: Where are we today?
    • Luban NLC : Transfusion safety: where are we today? Ann NY Acad Sci 1054 : 325 341, 2005
    • (2005) Ann NY Acad Sci , vol.1054 , pp. 325-341
    • Luban, N.L.C.1
  • 27
    • 54749102410 scopus 로고    scopus 로고
    • Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients
    • Kuo K-L, Hung S-C, Wei Y-H, Tarng D-C : Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 19 : 1817 1826, 2008
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1817-1826
    • Kuo, K.-L.1    Hung, S.-C.2    Wei, Y.-H.3    Tarng, D.-C.4
  • 28
    • 13644269314 scopus 로고    scopus 로고
    • Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: Immediate and long-term significance
    • Paraskevaidis IA, Iliodromitis EK, Vlahakos D, Tsiapras DP, Nikolaidis A, Marathias A, Michalis A, Kremastinos DT : Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 26 : 263 270, 2005
    • (2005) Eur Heart J , vol.26 , pp. 263-270
    • Paraskevaidis, I.A.1    Iliodromitis, E.K.2    Vlahakos, D.3    Tsiapras, D.P.4    Nikolaidis, A.5    Marathias, A.6    Michalis, A.7    Kremastinos, D.T.8
  • 30
    • 33947212276 scopus 로고    scopus 로고
    • Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study
    • the DRIVE Study Group
    • Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, the DRIVE Study Group : Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 18 : 975 984, 2007
    • (2007) J Am Soc Nephrol , vol.18 , pp. 975-984
    • Coyne, D.W.1    Kapoian, T.2    Suki, W.3    Singh, A.K.4    Moran, J.E.5    Dahl, N.V.6    Rizkala, A.R.7
  • 31
    • 85047696910 scopus 로고
    • Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients
    • Sundal E, Kaeser U : Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients. Nephrol Dial Transplant 4 : 979 987, 1989
    • (1989) Nephrol Dial Transplant , vol.4 , pp. 979-987
    • Sundal, E.1    Kaeser, U.2
  • 32
    • 66849138375 scopus 로고    scopus 로고
    • Arterial hypertension induced by erythropoietin and erythropoiesis- stimulating agents (ESA)
    • Krapf R, Hulter HN : Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 4 : 470 480, 2009
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 470-480
    • Krapf, R.1    Hulter, H.N.2
  • 33
    • 59149097688 scopus 로고    scopus 로고
    • Erythropoiesis-stimulating agent treatment with full anemia correction: A new perspective
    • Fishbane S : Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective. Kidney Int 75 : 358 365, 2009
    • (2009) Kidney Int , vol.75 , pp. 358-365
    • Fishbane, S.1
  • 34
    • 0033920429 scopus 로고    scopus 로고
    • Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure
    • DOI 10.1081/JDI-100100885
    • Conlon PJ, Kovalik E, Schumm D, Minda S, Schwab SJ : Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure. Ren Fail 22 : 435 444, 2000 (Pubitemid 30441639)
    • (2000) Renal Failure , vol.22 , Issue.4 , pp. 435-444
    • Conlon, P.J.1    Kovalik, E.2    Schumm, D.3    Minda, S.4    Schwab, S.J.5
  • 35
    • 0034055969 scopus 로고    scopus 로고
    • Normalization of hematocrit in hemodialysis patients does not affect silent ischemia
    • Conlon PJ, Kovalik E, Schumm D, Minda S, Schwab SJ : Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. Ren Fail 22 : 205 211, 2000
    • (2000) Ren Fail , vol.22 , pp. 205-211
    • Conlon, P.J.1    Kovalik, E.2    Schumm, D.3    Minda, S.4    Schwab, S.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.